Find your next paid study

Montefiore Medical CenterNCT07720856

Thoracic Aortic AneurysmPenetrating Aortic Ulcers (PAUs)Thoracic Aortic Dissection+1 more

Early Feasibility Study of the GORE® Multibranch Arch Endoprosthesis (MBA Device)

The MBA 25-04 study is a prospective, multicenter, non-randomized, single-arm, early feasibility study designed to assess the initial safety of the MBA device …

W.L.Gore & AssociatesNCT07564375

~$10 – $7,500

Recurrent Plasmablastic LymphomaRefractory Plasmablastic Lymphoma

Phase 1b Study of Teclistamab in Relapsed/Refractory Plasmablastic Lymphoma

This phase Ib trial tests the safety, side effects, and best dose of teclistamab in treating patients with plasmablastic lymphoma that has come back after a pe…

National Cancer Institute (NCI)NCT07332507

~$10 – $5,625

Birth DefectsMultiple Congenital AnomalyNeurodevelopmental Disorders

Virtual Platforms for Genetics Evaluation in the Medically Underserved

This study aims to transform the current clinical practice paradigm by leveraging an internally designed web-based model of delivery of care called Consultagen…

Baylor College of MedicineNCT05318222

Anterior Cruciate Ligament ReconstructionAnterior Cruciate Ligament InjuriesAnterior Cruciate Ligament Injury+1 more

EVALUATING A COMPREHENSIVE PSYCHOLOGICAL READINESS PROGRAM TO SUPPORT RETURN TO SPORT AFTER ACL RECONSTRUCTION: A RANDOMIZED CONTROLLED PILOT STUDY

The goal of this clinical trial is to learn whether an online mental and emotional support program called ACL Unbroken can help people recovering from ACL reco…

Inova Health Care ServicesNCT07851298

~$10 – $7,500

Solid Tumor, AdultMetastatic Breast CancerAdvanced Breast Cancer+8 more

A Phase 1a/1b Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of BBO-10203 in Subjects With Advanced Solid Tumors (The BREAKER-101 Study)

First in human study to evaluate the safety, tolerability, and pharmacokinetics (PK) of BBO-10203, a PI3Kα:RAS breaker, alone and in combination with other ant…

TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)NCT06625775

~$10 – $8,750

Breast ReconstructionDeep Inferior Epigastric PerforatorBreast Reconstruction After Mastectomy

A Prospective Pilot Study of Synthetic Electrospun Fiber Matrix in Abdominal Wall Donor Sites for Breast Reconstruction

This prospective single-arm pilot study will evaluate the application of meshed 5 × 7 cm Restrata® sheets to the abdominal wall donor site following deep infer…

Washington University School of MedicineNCT07851415

Rare CNS TumorFOXR2-activatedBCOR ITD Sarcoma+3 more

A Pilot Trial of Screening and Ultra-Rapid Profiling to Enable Real-Time Neuro-Oncology Validation and Actionable Treatment Selection for Patients With Relapsed or Recurrent Rare Brain Tumors

The current study will use a new treatment approach based on the molecular characteristics of each participant's tumor. The study will test the feasibility in …

Adriana FonsecaNCT07851636

~$10 – $7,500

Pioneering Research to Optimize Pre-exposure Prophylaxis (PrEP) Expansion With Lenacapavir (LEN)

The goal of this observational study is to generate real-life information on the use of lenacapavir (LEN, YEZTUGO®, (YTG)) for pre-exposure prophylaxis (PrEP) …

HIV Infections

Gilead SciencesNCT07473778

~$10 – $1,125

Phase 2

A Phase 2 Trial of Trastuzumab Deruxtecan in Combination With Cetuximab in HER2-low Metastatic Colorectal Cancer That Has Progressed on Standard Therapies

The purpose of this study is find out whether the combination of trastuzumab deruxtecan (T-DXd) and cetuximab is an effective treatment for participants with m…

Colorectal CancerAdenocarcinoma of the ColonAdenocarcinoma of the Rectum

Memorial Sloan Kettering Cancer CenterNCT07691489

HIV InfectionsAlcohol DrinkingAging+1 more

Geroprotective Precision Medicine Strategies in PWH That Use Alcohol

People with HIV who drink alcohol are at increased risk for accelerated aging biology, including increased immune senescence. This randomized, double-blind, cr…

Louisiana State University Health Sciences Center in New OrleansNCT07462767

Heart Failure With Reduced Ejection Fraction

A Multi-center, Randomized, Participant- and Investigator- Blinded, Placebo-controlled Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of HJB647 in Participants With Chronic Stable Heart Failure With Reduced Ejection Fraction

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of HJB647 at two different doses in participants with chronic stable he…